Compare LNTH & BXSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LNTH | BXSL |
|---|---|---|
| Founded | 1956 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.5B |
| IPO Year | 2014 | 2018 |
| Metric | LNTH | BXSL |
|---|---|---|
| Price | $109.13 | $23.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $87.00 | $27.18 |
| AVG Volume (30 Days) | 864.4K | ★ 1.8M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 12.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.80 | 0.11 |
| Revenue | ★ $343,374,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.19 | N/A |
| P/E Ratio | ★ $60.56 | $217.09 |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $47.27 | $22.47 |
| 52 Week High | $111.86 | $32.81 |
| Indicator | LNTH | BXSL |
|---|---|---|
| Relative Strength Index (RSI) | 66.22 | 48.00 |
| Support Level | $95.00 | $23.26 |
| Resistance Level | N/A | $24.99 |
| Average True Range (ATR) | 3.08 | 0.46 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 71.02 | 29.33 |
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies.